Edition:
United States

Geron Corp (GERN.OQ)

GERN.OQ on NASDAQ Stock Exchange Global Select Market

2.24USD
4:00pm EDT
Change (% chg)

$0.02 (+0.90%)
Prev Close
$2.22
Open
$2.22
Day's High
$2.38
Day's Low
$2.21
Volume
388,497
Avg. Vol
271,036
52-wk High
$3.35
52-wk Low
$1.81

Latest Key Developments (Source: Significant Developments)

Geron Corp says 2 parties to securities class action executed a stipulation and agreement of settlement to settle securities class action
Friday, 3 Mar 2017 07:45am EST 

Geron Corp : Geron corp says on March 2 parties to securities class action executed a stipulation and agreement of settlement to settle securities class action . Geron Corp says settlement does not constitute any admission of fault or wrongdoing by company or any of individual defendants . Geron Corp says expects $6.0 million of settlement amount to be paid by co's insurance providers and remaining $250,000 to be paid by co - SEC filing .Geron says in exchange for dismissal with prejudice of all claims against all defendants in lawsuit, co to settle securities class action for $6.25 million in cash.  Full Article

Geron qtrly loss per share $0.05
Wednesday, 1 Mar 2017 04:05pm EST 

Geron Corp : Geron Corporation reports fourth quarter and annual 2016 financial results .Qtrly loss per share $0.05.  Full Article

Geron Corp reports loss per share of $0.02
Thursday, 3 Nov 2016 08:26pm EDT 

Geron Corp : Geron Corporation reports third quarter 2016 financial results and recent events . Q3 loss per share $0.02 . Q3 revenue $5.1 million . Q3 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S .Q3 revenue view $156,000 -- Thomson Reuters I/B/E/S.  Full Article

Geron Corp reports loss per share of $0.02
Thursday, 3 Nov 2016 04:05pm EDT 

Geron Corp : Geron Corporation reports third quarter 2016 financial results and recent events . Q3 loss per share $0.02 . Q3 revenue $5.1 million . Q3 earnings per share view $-0.06 -- Thomson Reuters I/B/E/S .Q3 revenue view $156,000 -- Thomson Reuters I/B/E/S.  Full Article

Geron Corp Q2 loss per share $0.05
Wednesday, 3 Aug 2016 04:05pm EDT 

Geron Corp : Q2 loss per share $0.05 . Q2 revenue $211,000 . Geron corporation reports second quarter 2016 financial results and recent events . Q2 earnings per share view $-0.07 -- Thomson Reuters I/B/E/S .Q2 revenue view $302,000 -- Thomson Reuters I/B/E/S.  Full Article

Geron Announces Initiation of Janssen Phase 2 Clinical Trial of Imetelstat in Myelofibrosis
Wednesday, 16 Sep 2015 07:30am EDT 

Geron Corporation:Announces that it has initiated a new site for its ongoing Phase 1/2a TT-034 trial at the Methodist Health System Clinical Research Institute in Dallas, Texas.Says the site has commenced pre-screening hepatitis C patients and is led by principal investigator Parvez Mantry, a gastroenterologist and hepatologist.  Full Article

More From Around the Web

BRIEF-Geron qtrly loss per share $0.05

* Geron Corporation reports fourth quarter and annual 2016 financial results